ALT
Price
$8.25
Change
+$0.07 (+0.86%)
Updated
Dec 20 closing price
96 days until earnings call
PLRX
Price
$13.22
Change
-$0.08 (-0.60%)
Updated
Dec 20, 04:59 PM (EDT)
73 days until earnings call
Ad is loading...

ALT vs PLRX

Header iconALT vs PLRX Comparison
Open Charts ALT vs PLRXBanner chart's image
Altimmune
Price$8.25
Change+$0.07 (+0.86%)
Volume$4.9M
CapitalizationN/A
Pliant Therapeutics
Price$13.22
Change-$0.08 (-0.60%)
Volume$82.26K
CapitalizationN/A
ALT vs PLRX Comparison Chart
Loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALT vs. PLRX commentary
Dec 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALT is a Hold and PLRX is a Hold.

COMPARISON
Comparison
Dec 21, 2024
Stock price -- (ALT: $8.27 vs. PLRX: $13.22)
Brand notoriety: ALT and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALT: 140% vs. PLRX: 357%
Market capitalization -- ALT: $587.85M vs. PLRX: $804.48M
ALT [@Biotechnology] is valued at $587.85M. PLRX’s [@Biotechnology] market capitalization is $804.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALT’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • ALT’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALT and PLRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALT’s TA Score shows that 5 TA indicator(s) are bullish while PLRX’s TA Score has 4 bullish TA indicator(s).

  • ALT’s TA Score: 5 bullish, 4 bearish.
  • PLRX’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, ALT is a better buy in the short-term than PLRX.

Price Growth

ALT (@Biotechnology) experienced а -8.47% price change this week, while PLRX (@Biotechnology) price change was -0.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

ALT is expected to report earnings on Mar 27, 2025.

PLRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($804M) has a higher market cap than ALT($588M). ALT (-26.533) and PLRX (-27.002) have similar YTD gains . ALT has higher annual earnings (EBITDA): -103.19M vs. PLRX (-197.04M). PLRX has more cash in the bank: 405M vs. ALT (139M). ALT has less debt than PLRX: ALT (1.77M) vs PLRX (60.2M). ALT has higher revenues than PLRX: ALT (52K) vs PLRX (0).
ALTPLRXALT / PLRX
Capitalization588M804M73%
EBITDA-103.19M-197.04M52%
Gain YTD-26.533-27.00298%
P/E RatioN/AN/A-
Revenue52K0-
Total Cash139M405M34%
Total Debt1.77M60.2M3%
FUNDAMENTALS RATINGS
ALT: Fundamental Ratings
ALT
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
74
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALTPLRX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 1 day ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 3 days ago
71%
View a ticker or compare two or three
Ad is loading...
ALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBRIX13.890.25
+1.83%
Neuberger Berman Real Estate I
HGITX54.090.53
+0.99%
Hartford Core Equity R5
MENIX9.660.09
+0.94%
Madison Covered Call & Equity Income I
DIFAX12.080.06
+0.50%
MFS Diversified Income A
FCAOX12.09N/A
N/A
Fidelity Advisor Climate Action M

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with NTLA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
-0.60%
NTLA - PLRX
52%
Loosely correlated
+1.08%
BEAM - PLRX
50%
Loosely correlated
+8.16%
RCKT - PLRX
50%
Loosely correlated
+2.03%
CRSP - PLRX
50%
Loosely correlated
+0.83%
ETNB - PLRX
49%
Loosely correlated
+12.80%
More